Dziedzic A - Search Results

1

Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment.

Dziedzic A, Maciak K, Miller ED, Starosta M, Saluk J. Dziedzic A, et al. Int J Mol Sci. 2024 Mar 29;25(7):3858. doi: 10.3390/ijms25073858. Int J Mol Sci. 2024. PMID: 38612668 Free PMC article. Review.

2

[The inflammatory processes in atherogenesis].

Cichoń N, Lach D, Dziedzic A, Bijak M, Saluk J. Cichoń N, et al. Among authors: dziedzic a. Pol Merkur Lekarski. 2017 Mar 21;42(249):125-128. Pol Merkur Lekarski. 2017. PMID: 28333905 Review. Polish.

3

[Inflammatory processes in the pathogenesis of acute coronary syndromes].

Lach D, Cichon N, Dziedzic A, Bijak M, Saluk J. Lach D, et al. Among authors: dziedzic a. Pol Merkur Lekarski. 2017 May 23;42(251):183-186. Pol Merkur Lekarski. 2017. PMID: 28557963 Review. Polish.

4

Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients.

Bijak M, Olejnik A, Rokita B, Morel A, Dziedzic A, Miller E, Saluk-Bijak J. Bijak M, et al. Among authors: dziedzic a. J Cell Mol Med. 2019 May;23(5):3476-3482. doi: 10.1111/jcmm.14244. Epub 2019 Mar 5. J Cell Mol Med. 2019. PMID: 30838756 Free PMC article.

5

A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.

Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M. Miller ED, et al. Among authors: dziedzic a. Nutrients. 2019 Jul 5;11(7):1528. doi: 10.3390/nu11071528. Nutrients. 2019. PMID: 31284389 Free PMC article. Review.

6

The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis.

Dziedzic A, Miller E, Saluk-Bijak J, Bijak M. Dziedzic A, et al. Int J Mol Sci. 2020 Mar 8;21(5):1852. doi: 10.3390/ijms21051852. Int J Mol Sci. 2020. PMID: 32182666 Free PMC article. Review.

7

Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis.

Dziedzic A, Morel A, Miller E, Bijak M, Sliwinski T, Synowiec E, Ceremuga M, Saluk-Bijak J. Dziedzic A, et al. Oxid Med Cell Longev. 2020 Jun 17;2020:2868014. doi: 10.1155/2020/2868014. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32655763 Free PMC article.

8

Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.

Dziedzic A, Saluk-Bijak J, Miller E, Bijak M. Dziedzic A, et al. Int J Mol Sci. 2020 Aug 19;21(17):5957. doi: 10.3390/ijms21175957. Int J Mol Sci. 2020. PMID: 32825027 Free PMC article. Review.

9

Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.

Dziedzic A, Miller E, Bijak M, Przyslo L, Saluk-Bijak J. Dziedzic A, et al. Int J Mol Sci. 2020 Oct 19;21(20):7722. doi: 10.3390/ijms21207722. Int J Mol Sci. 2020. PMID: 33086557 Free PMC article.

10

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.

Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. Dziedzic A, et al. Int J Mol Sci. 2021 Feb 11;22(4):1804. doi: 10.3390/ijms22041804. Int J Mol Sci. 2021. PMID: 33670394 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters